Arcturus Therapeutics Comparables

Find the most relevant public market comparables for Arcturus Therapeutics, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

Arcturus Therapeutics is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. They utilize proprietary lipid-mediated delivery systems (LUNAR®) and STARR® mRNA technology (sa-mRNA) for the discovery, development, and commercialization of mRNA medicines for rare and infectious diseases.

Business Model

Discovery, development, and commercialization of mRNA medicines and vaccines.

Target Customers

Patients with rare diseases (e.g., ornithine transcarbamylase deficiency, cystic fibrosis), and the general population for infectious disease vaccines (e.g., COVID-19, influenza).

Specific Focus

mRNA medicines and vaccines, particularly self-amplifying mRNA (sa-mRNA) technology for infectious diseases and rare diseases.

Location

San Diego, California

CEO

Joseph E. Payne

Industry

Life sciences

Sub Sector

RNA Therapeutics

3yr Revenue Growth

1,554%

Public Market Comparables

Below are the key valuation metrics for companies similar to Arcturus Therapeutics in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Arcturus Therapeutics? Our platform provides detailed analysis of Arcturus Therapeutics's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Arcturus Therapeutics compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Arcturus Therapeutics comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Arcturus Therapeutics Compset

As a leading player in the Life sciences industry within the Biotechnology sector, Arcturus Therapeutics operates in the specialized RNA Therapeutics sub-sector. Understanding how Arcturus Therapeutics compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the RNA Therapeutics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Arcturus Therapeutics and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free